Dr. Theresa L. Labarte, DO

Dr. Labarte practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Labarte's NPI, 1073830675, was assigned on April 23, 2010. Dr. Labarte graduated from LECOM at Seton Hill - Greensburg in 2010. Dr. Labarte holds California license 20A11876.

Dr. Labarte's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Labarte's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Labarte is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Labarte to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Labarte practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Labarte's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Labarte is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dr. Labarte is licensed in California.

Dmand AI lists hereditary polyneuropathy, neuropathy and restless legs syndrome among the conditions Dr. Labarte treats.

CMS data shows 89 Medicare services from Dr. Labarte across 3 procedure codes in 2024, for 92 Medicare patients. Medicare paid $6,324 for them.

CMS counts 92 Medicare patients who saw Dr. Labarte in 2024. The largest group is 65 to 74, with 37 patients. 74% of them have high blood pressure, and 71% have high cholesterol. 59% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Labarte's median patient age at 55, with 64% women.

In 2024, Dr. Labarte wrote 204 Medicare Part D claims for 43 patients. 76% of them were for generic drugs. CMS names the drug for 122 of them, across 7 drugs with 11 or more claims each, at $1,435,906 in total drug cost. In 2023, CMS named 150 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Labarte for performance year 2024, reported as part of a group. Dr. Labarte accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Labarte as offering telehealth.

Dmand AI links 1 paper to Dr. Labarte in 2025. Dr. Labarte's most frequent co-author is Cattien Ngoc Phan, DO.

CMS Open Payments shows 13 general payments to Dr. Labarte from 3 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 84% of the total. Gilead Sciences, Inc. paid the most, $99.

Dr. Labarte graduated from LECOM at Seton Hill - Greensburg in 2010.

Dr. Labarte is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.